Beam Therapeutics (BEAM) FCF Margin Growth (1y) (2020 - 2026)
Beam Therapeutics (BEAM) FCF Margin Growth (1y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
5,389.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,525.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Beam Therapeutics |
3.53 Bn |
3.53 Bn |
- |
99,821.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
99,821.00 |
| Dec 31, 2025 |
16,552.00 |
| Sep 30, 2025 |
-15,263.00 |
| Jun 30, 2025 |
-25,256.00 |
| Mar 31, 2025 |
-5,922.00 |
| Dec 31, 2024 |
-27,846.00 |
| Sep 30, 2024 |
-8,739.00 |
| Jun 30, 2024 |
-22,835.00 |
| Mar 31, 2024 |
-85,322.00 |
| Dec 31, 2023 |
60,297.00 |
| Sep 30, 2023 |
-24,405.00 |
| Jun 30, 2023 |
-3,426.00 |
| Mar 31, 2023 |
-300,284.00 |
| Dec 31, 2022 |
-61,231.00 |
| Sep 30, 2022 |
308,386.00 |
| Jun 30, 2022 |
42.42 Mn |
| Mar 31, 2022 |
83.68 Mn |
| Dec 31, 2021 |
44.27 Mn |
| Sep 30, 2021 |
38.45 Mn |
| Jun 30, 2021 |
-4.88 Mn |
